The authors confirmed previous findings where increased miR-221 levels in advanced stages of HCC influenced the invasion and migration of tumors, and additionally discovered SOCS3, an inhibitor of the JAK/STAT pathway, as a target of miR-221. The gene discussed is SOCS3; the disease is hepatocellular carcinoma.